Wenyan Cai

Wenyan Cai is a seasoned professional in the field of bioanalytics and therapeutic antibody discovery, currently serving as Senior Manager, Bioanalytics at Prothena Corporation since May 2022. Previous roles include Senior Scientific Project Manager at Ab Studio, where management of immune oncology projects was key, and Director at Genorbio Pharma, focusing on restructuring the antibody discovery department. Wenyan has a strong background in leading bispecific antibody projects at Ab Studio Inc. and overseeing therapeutic antibody discovery at WuXi AppTec, Novartis, and ChemPartner. Currently pursuing an Executive MBA at Santa Clara University, Wenyan holds a Master's degree in Biological Engineering from Fudan University.